CIK 0001237831 · Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043744954
- Phone
- 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,970,014
- in 4 filings, $425K under 10b5-1 plans
Net −$7,970,014. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-26 | Pfeil Keith W SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +60,000 | 60,000 | ||
| 2024-01-26 | Scavilla Daniel T President, CEO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +140,000 | 140,000 | ||
| 2024-01-26 | Paul David C Executive Chairman | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +75,000 | 75,000 | ||
| 2024-01-18 | Davidar David D Director | Gift | −8,000 | 586,275 | ||
| 2023-12-05 | Paul David C Executive Chairman | Gift · Class B Common Stock | −342,200 | 20,525,324 | ||
| 2023-12-05 | Paul David C Executive Chairman | Gift · Class B Common Stock | +171,100 | 171,100 | ||
| 2023-12-05 | Paul David C Executive Chairman | Gift · Class B Common Stock | +171,100 | 171,100 | ||
| 2023-10-10 | Scavilla Daniel T President, CEO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +10,000 | 10,000 | ||
| 2023-10-10 | Pfeil Keith W SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +5,000 | 5,000 | ||
| 2023-10-10 | Huller Kelly SVP, GC, Corporate Secretary | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +5,000 | 5,000 | ||
| 2023-09-01 | DeFord John A Director | Grant or award | +15,578 | 15,578 | ||
| 2023-09-01 | DeFord John A Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-09-01 | Wolterman Dan Director | Grant or award | +24,025 | 24,025 | ||
| 2023-09-01 | Wolterman Dan Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-09-01 | Norwalk Leslie V Director | Grant or award | +2,321 | 2,321 | ||
| 2023-09-01 | Norwalk Leslie V Director | Grant or award | +25,688 | 28,009 | ||
| 2023-09-01 | Norwalk Leslie V Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-09-01 | DeFord John A Director | Grant or award | +15,578 | 15,578 | ||
| 2023-09-01 | DeFord John A Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-05-15 | Lemaitre Dan Director | Option exercise | +1,450 | $23.95 | $35K | 12,250 |
Page 9 of 10 · 200 trades